Neurohormonal control of gallbladder motility

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 8, 1997, Pages 737-750

  Niebergall Roth, E ^a   Teyssen, S ^a   Singer, M V ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CHOLECYSTOKININ; GASTRIN RELEASING PEPTIDE; LOXIGLUMIDE; MOTILIN; NEUROHORMONE; NITRIC OXIDE; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

CHOLECYSTOGRAPHY; CHOLINERGIC SYSTEM; ECHOGRAPHY; GALLBLADDER MOTILITY; GALLBLADDER SCINTISCANNING; HUMAN; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CATS; DOGS; EATING; GALLBLADDER; GALLBLADDER EMPTYING; GASTROINTESTINAL HORMONES; GUINEA PIGS; HUMANS; MUSCLE CONTRACTION;

EID: 0030849667     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (192)

1. Ivy AC, Bergh GS. The applied physiology of the extrahepatic biliary tract. JAMA 1934;103:1500-4.
2. Svanvik J, Allen B, Pellegrini C, Bernhoft R, Way L. Variations in concentrating function of the gallbladder in the conscious monkey. Gastroenterology 1984;86:919-25.
3. 99mTc-labeled diethyl-iminodiacetic acid scintigraphy. Scand J Gastroenterol 1993;28:709-13.
4. Schusdziarra V. Gastrointestinale Hormone und Neuropeptide. Stuttgart: Kohlhammer; 1985.
5. Lamers CBHW, Jansen JBMJ. Cholinergic and hormonal regulation of post-prandial gallbladder contraction in humans. In: Singer MV, Goebell H, editors. Nerves and the gastrointestinal tract. Lancaster: Kluwer; 1989. p. 213-8.
6. Niebergall-Roth E, Teyssen S, Singer MV. Neurohormonal control of gallbladder motility by intraileal and intracolonic nutrients - review. Berl Muench Tieraerztl Wochenschr 1996; 109:87-94.
7. Svenberg T, Christofides ND, Fitzpatrick ML, Areola-Oritz F, Bloom SR, Williams RB. Interdigestive biliary output in man: relationship to fluctuations in plasma motilin and effect of atropine. Gut 1982;23:1024-8.
8. Schwartz TW, Stenquist B, Olbe L. Cephalic phase of pancreatic polypeptide secretion studied by sham feeding in man. Scand J Gastroenterol 1979;14:313-20.
9. Taylor IL, Feldman M, Richardson CT, Walsh JH. Gastric and cephalic stimulation of human pancreatic polypeptide release. Gastroenterology 1978;75:432-7.
10. Taylor IL, Impicciatore M, Carter DC, Walsh JH. Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol 1978;235:E443-7.
11. Lonovics J, Guzman S, Devitt P, Hejtmancik KE, Suddith RL, Rayford PL, et al. Release of pancreatic polypeptide in humans by infusion of cholecystokinin. Gastroenterology 1980;79:817-22.
12. Hildebrand P, Beglinger C, Gyr K, Jansen JBMJ, Rovati LC, Zuercher M, et al. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary response in man. J Clin Invest 1990;85:640-6.
13. Schaffalitzky de Muckadell OB, Fahrenkrug J, Holst JJ. Release of vasoactive intestinal polypeptide (VIP) by electrical stimulation of the vagal nerves. Gastroenterology 1977;72: 373-5.
14. Ryan JP. Motility of the gallbladder and biliary tree. In: Johnson LR, editor. Physiology of the gastrointestinal tract. 2nd ed. New York: Raven Press; 1987. p. 695-721.
15. Park CY, Pae YS, Hong SS. Radiologic studies on emptying of the huamn gallbladder. Am Surg 1970;171:294-9.
16. Herzog RJ, Nelson JA. The role of cholecystokinin in radiographic opacification of the gallbladder. Invest Radiol 1076;11:440-7.
17. Levitt MD, Bond J. Use of the constant perfusion tehcnique in the nonsteady state. Gastroenterology 1977;73:1450-3.
18. Englert E, Chiu VS. Quantitation analysis of human biliary evacuation with a radioisotopic technique. Gastroenterology 1966;50:506-18.
19. Krishnamurthy GT, Bobba VR, Kingston E. Radionuclide ejection fraction: a technique for quantitative analysis of motor function of the human gallbladder. Gastroenterology 1981;80:482-90.
20. Everson GT, Braverman DZ, Johnson ML, Kern F Jr. A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 1980; 79:40-6.
21. Moreland AF. Collection and withdrawal of body fluids and infusion techniques. In: Gay WI, editor. Methods of animal experimentation. Vol. I. New York: Academic Press; 1965. p. 1-42.
22. Debas HT, Yamagishi T. Evidence for a pyloro-cholecystic reflex for gallbladder contraction. Ann Surg 1979;190:170-6.
23. Strah KM, Pappas TN, Melendez RL, Debas HT. Contrasting cholinergic dependence of pancreatic and gallbladder response to cholecystokinin. Am J Physiol 1986;250:G665-9.
24. Keane FB, DiMagno EP, Dozois RR, Go VLW. Relationship among canine interdigestive exocrine pancreatic and biliary flow, duodenal motor activity, plasma pancreatic polypeptide and motilin. Gastroenterology 1980;78:310-6.
25. Traynor OJ, Dozois RR, DiMagno EP. Canine interdigestive and postprandial gallbladder motility and emptying. Am J Physiol 1984;246:G426-32.
26. Ura K, Sarna SK, Condon RE. Antral control of gallbladder cyclic motor activity in the fasting state. Gastroenterology 1992;102:295-302.
27. Tanaka M, Sarr MG, Miller LJ, Malgelada J-R. Changes in tone of canine gallbladder measured by an electronic pneumatic barostat. Am J Physiol 1990;259:G314-20.
28. Itoh Z, Takahashi I. Periodic contractions of the canine gallbladder during the interdigestive state. Am J Physiol 1981; 240:G183-9.
29. Matsumoto T, Sarna SK, Condon RE, Dodds WJ, Mochinaga N. Canine gallbladder cyclic motor activity. Am J Physiol 1988;225:G409-16.
30. Takahashi I, Nakaya M, Suzuki T, Itoh Z. Postprandial changes in contractile activity and bile concentration in gallbladder of the dog. Am J Physiol 1982;243:G365-71.
31. Peeters TL, Vantrappen G, Janssens J. Bile acid output and the interdigestive migrating complex in normals and in cholecystectomized patients. Gastroenterology 1980;79:678-86.
32. Boldyreff W. Einige neue Seiten der Tätigkeit des Pankreas: Der Übertritt des Pankreassaftes und anderer Darmsekrete in den Magen; die physiologische und klinische Bedeutung dieser Erscheinung. Ergeb Physiol 1911;11:185-217.
33. Itoh Z, Takahashi I, Nakaya M, Suzuki T, Arai H, Wakbayashi K. Interdigestive gallbladder bile concentration in relation to periodic contraction of gallbladder in the dogs. Gastroenterology 1982;83:645-51.
34. Scott RB, Eidt PB, Shaffer EA. Regulation of fasting canine duodenal bile acid delivery by sphincter of Oddi and gallbladder. Am J Physiol 1985;249:G622-33.
35. Marzio L, Matteo N, Capone F, DiFelice F, De Angelis C, Mezzetti A, et al. Gallbladder contraction and its relationship to interdigestive duodenal motor activity in normal human subjects. Dig Dis Sci 1988;33:540-4.
36. Qvist N, Øster-Jørgensen E, Rasmussen L, Kraglund K, Pedersen SA. The relationship between gallbladder dynamics and the migrating motor complex in fasting healthy subjects. Scand J Gastroenterol 1988;23:562-6.
37. DiMagno EP, Hendricks JC, Go VLW, Dozois RR. Relationships among canine fasting pancreatic and biliary secretions, pancreatic duct pressure, and duodenal phase III motor activity - Boldyreff revisited. Dig Dis Sci 1979;24:689-93.
38. Stolk MFJ, van Erepecum KJ, Smout AJPM, Akkermans LMA, Jansen JBMJ, Lamers CBHW, et al. Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gallbladder emptying. Am J Physiol 1993;264: G596-600.
39. Magee DF, Naruse S, Pap A. Vagal control of gallbladder contraction. J Physiol 1984;355:65-70.
40. Abiru H, Sarna SK, Condon RE. Contractile mechanisms of gallbladder filling and emptying in dogs. Gastroenterology 1994;106:1652-61.
41. Code CF, Schlegel JF. The gastrointestinal interdigestive housekeeper: motor correlates of the interdigestive myoelectric complex of the dog. In: Daniel EE, editor. Proceedings of the 4th International Symposium on GI Motility. Vancouver: Mitchell; 1973. p. 631-4.
42. Takahashi T, May D, Owyang C. Cholinergic dependence of gallbladder response to cholecystokinin in the guinea pig in vivo. Am J Physiol 1991;261:G565-9.
43. Johnson FE, Boyden EA. The effect of double vagotomy on the motor activity on the human gallbladder. Surgery 1952;32: 591-601.
44. Parkin GJS, Smith RB, Johnston D. Galbladder volume contractility after truncal, selective and highly selective (parietal-cell) vagotomy in man. Ann Surg 1972;178:581-6.
45. Polak JM, Pearse AGE, Garaud J-C, Bloom SR. Cellular localization of vasoactive intestinal peptide in the mamalian and avian gastrointestinal tract. Gut 1974;15:720-4.
46. Sundler F, Alumets J, Håkanson R, Ingemansson S, Fahrenkrug J, Schaffalitzky de Muckadell O. VIP innervation of the gallbladder. Gastroenterology 1977;72:1375-7.
47. Jansson R, Steen G, Svanvik J. Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat. Gastroenterology 1978;75:47-50.
48. Vagne M, Troitskoja V. Effects of secretin, glucagon, and VIP on gallbladder contraction. Digestion 1976;14:62-7.
49. Ryan JP, Cohen S. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin induced gallbladder pressure. Gastroenterology 1977;73:870-2.
50. Bryant MG, Bloom SR, Polak JM. Possible dual role of vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet 1976;1:991-3.
51. Bult H, Boeckxstaens GE, Pewlckmans PA, Jordaens FH, Van Maercke YM, Herman AG. Nitric oxide as an inhibitory non-adrenergic non-cholinerigc neurotransmitter. Nature 1990; 345: 346-7.
52. Mourelle M, Guarner F, Molero X, Moncada S, Malagelada J-R. Regulation of gallbladder motility by the arginine-nitric oxide pathway in guinea pigs. Gut 1993;34:911-5.
53. Schjoldager B, Poulsen SS, Schmidt P, Coy DH, Holst JJ. Gastrin-releasing peptide is a transmitter mediating porcine gallbladder contraction. Am J Physiol 1991;260:G577-85.
54. Helmstaedter V, Kreppein W, Domschke W, Mitznegg P, Yanaihara N, Wunsch E, et al. Immunohistochemical localization of motilin in endocrine cells of the small intestine of humans and monkey. Gastroenterology 1979;76:897-902.
55. Itoh Z, Takeuchi S, Aizawa I, Mori K, Taminato T, Seino Y, et al. Changes in plasma motilin concentration and gastrointestinal contractile activity in conscious dogs. Am J Dig Dis 1978; 23:929-35.
56. Lee KY, Chey WY, Tai H-H, Yajima H. Radioimmunoassay of motilin: validation of studies on the relationship between plasma motilin and interdigestive myoelectric activity of the duodenum of the dog. Am J Dig Dis 1978;23:789-95.
57. Suzuki T, Takahashi I, Itoh Z. Motilin and gallbladder: New dimensions in gastrointestinal physiology. Peptides 1981;2: 229-33.
58. Takahashi I, Suzuki T, Aizawa I, Itoh Z. Comparison of gallbladder contractions induced by motilin and cholecystokinin in dogs. Gastroenterology 1982;82:419-24.
59. Nilsson BI, Svenberg T, Tollström T, Hellström PM, Samuelson K, Schnell P-O. Relationship between interdigestive gallbladder emptying, plasma motilin and migrating motor complex in man. Acta Physiol Scand 1990;139:55-61.
60. Meyer BM, Beglinger C, Jansen JBMJ, Rovati LC, Werth BA, Hildebrand P, et al. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989;2:12-5.
61. Niederau C, Heintges T, Rovati L, Strohmeyer G. Effects of loxiglumide on gallbladder emptying in healthy volunteers. Gastroenterology 1989;97:1331-6.
62. Malesci A, DeFazio C, Festorazzi S, Bonato C, Valentini A, Taccont M, et al., Effect of loxiglumide on gallbladder contractile reponse to cerulein and food in humans. Gastroenterology 1990;98:1307-10.
63. Schmidt WE, Creutzfeld W, Schleser A, Choudhury AR, Nustede R, Höcker M, et al. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effect of loxiglumide. Am J Physiol 1991;260:G197-206.
64. Liddle RA, Geertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, et al. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. J Clin Invest 1989; 84:1220-5.
65. Chen YF, Chey WY, Lee KY, Chang TM. Cyclic change in plasma concentration and exocrine pancreatic secretion in the interdigestive state of dog. Gastroenterology 1983;84:1122.
66. Dale WE, Turkelson CM, Solomon TE. Role of cholecystokinin in intestinal phase and meal-induced pancreatic secretion. Am J Physiol 1989;257:G782-90.
67. Burgess R, Ling N, Butcher M, Guillemin R. Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proc Natl Acad Sci USA 1973;70:684-8.
68. Schusdziarra V. Somatostatin - physiological and pathophysiological aspects. Scand J Gastroenterol 1983;18 Suppl 82:69-84.
69. Aizawa I, Itoh Z, Harris V, Unger RH. Plasma somatostatin-like immunoreactivity during the interdigestive period in the dog. J Clin Invest 1981;68:206-13.
70. Creutzfeld W, Lankisch PG, Folsch UR. Hemmung der sekretin- und cholecystokinin-pankreozymin-induzierten Saftund Enzymsekretion des Pankreas und der Gallenblasenkontraktion beim Menschen durch Somatostatin. Dtsch Med Wochenschr 1975;100:1135-8.
71. Fisher RS, Rock E, Levin G, Malmud LS. Effects of somatostatin on gallbladder emptying. Gastroenterology 1987; 92:885-90.
72. Lin T-M, Chance RE. Spectrum of gastrointestinal actions of bovine PP. In: Bloom SR, editor. Gut hormones. Edinburgh: Churchill Livingstone; 1978. p. 242-6.
73. Gepts W, Baetens D, DeMay J. The PP cell. In: Bloom SR, editor. Gut hormones. Edinburgh: Churchill Livingstone; 1978. p. 229-33.
74. Pomeranz IS, Davison JS, Shaffer EA. In vitro effects of pancreatic polypeptide and motilin on contractility of human gallbladder. Dig Dis Sci 1983;28:539-44.
75. Chen MH, Joffe SN, Magee DF, Murphy RF, Naruse S. Cyclic changes of plasma pancreatic polypeptide and pancreatic secretion in fasting dogs. J Physiol 1983;341:453-41.
76. Owyang C, Achem-Karam SR, Vinik AI. Pancreatic polypeptide and intestinal migrating motor complex in humans. Effect of pancreaticobiliary secretion. Gastroenterology 1983;84:10-7.
77. Adrian TE, Mitchenere P, Sagor G, Bloom SR. Effect of pancreatic polypeptide on gallbladder pressure and hepatic bile secretion. Am J Physiol 1982;243:G204-7.
78. Greenberg GR, McCloy RF, Chadwick VS, Adrian TE, Baron JH, Bloom SR. Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man. Dig Dis Sci 1979;24:11-14.
79. Conter RL, Roslyn JJ, Muller EL, Pitt HA, Porter-Fink V, Den Besten L, et al. Effect of pancreatic polypeptide on gallbladder filling. J Surg Res 1985;38:461-7.
80. Starke K, Lembeck F, Lorenz W, Weiss U. Gallen- und Pankreas-Sekretion unter Substanz P und einem Physalämin-Derivat. Naunyn Schmiedebergs Arch Pharmakol 1968;260: 269-74.
81. Lonovics J, Varro V, Thompson JC. The effect of cholecystokinin and substance P antagonists on cholecystokinin- and substance P-stimulated gallbladder contraction. Gastroenterology 1985;88:1637A.
82. Hanyu N, Dodds WJ, Layman RD, Hogan WJ, Colton DG. Effect of two new cholecystokinin antagonists on gallbladder emptying in opossums. Am J Physiol 1991;260:G258-64.
83. Strunz U, Domschke W, Mitznegg P, Domschke S, Schubert E, Wunsch E, et al. Analysis of the motor effects of 13-norleucin motilin on the rabbit, guinea pig, rat, and human alimentary tract in vitro. Gastroenterology 1975;86:1485.
84. Yamasaki T, Chijiiwa K, Chijiiwa Y. Direct contractile effect of motilin on isolated smooth muscle cells from human gallbladder. J Surg Res 1994;56:89-93.
85. Gürtler H. Die Physiologie der Verdauung und Absorption. In: Kolb E, ed. Lehrbuch der Physiologie der Haustiere. 4th ed. Jena: Fischer; 1980. p. 177-338.
86. Fisher RS, Rock E, Malmud LS. Gallbladder emptying response to sham feeding in humans. Gastroenterology 1986; 90:1854-7.
87. Hopman WPM, Jansen JBMJ, Rosenbusch G, Lamers CBHW. Cephalic stimulation of gallbladder contraction in humans: Role of cholecystokinin and the cholinergic system. Digestion 1987;38:197-203.
88. Yamamura T, Takahashi T, Kusunoki M, Kantoh M, Seino Y, Utsunomiya J. Gallbladder dynamics and plasma cholecystokinin responses after meals, oral water, or sham feeding in healthy subjects. Am J Med Sci 1988;295:102-7.
89. Vermeulen M, Hopman WPM, de Jong AJL, Yap SH, Lamers CBHW. Vagale stimulatie van pancreas en galblaas bij patienten met achalasie. Ned Tijdschr Geneesk 1985;129:1657.
90. Read NW, Cooper K, Fordtran JS. Effect of modified sham feeding on jejunal transport and pancreatic and biliary secretion in man. Am J Physiol 1978;234:417-20.
91. Hansen WE, Maurer H, Haberland H. The effect of shamfeeding on gallbladder volume and circulation of bile acids. Hepatogastroenterol 1982;29:108-10.
92. Tankhurt E, Yegen BÇ, Biren T, Gürmen N, Onat F, Ercil A, et al. Influence of pirenzepine on gallbladder contraction in man induced by sham feeding or an intraduodenal meal. Digestion 1992;51:103-9.
93. Walsh JH, Grossman MI. Gastrin. N Engl J Med 1975;297: 1324-34.
94. Knutson U, Olbe L, Ganguli PC. Gastric acid and plasma gastrin response to sham feeding in duodenal ulcer patients before and after resection of antrum and duodenal bulb. Scand J Gastroenterol 1974;9:351-6.
95. Nilsson G, Simon J, Yalow RS. Plasma gastrin and gastric acid responses to sham feeding and feeding in dogs. Gastroenterology 1972;63:51-9.
96. Tepperman BL, Walsh JH, Preshaw RM. Effect of antral denervation on gastrin release by sham feeding and insulin hypoglycemia in dogs. Gastroenterology 1972;63:973-80.
97. Csendes A, Walsh JH, Grossman MI. Effects of atropine and of antral acidification on gastrin release and amino acid secretion in response to insulin and feedings in dogs. Gastroenterology 1972;63:257-63.
98. Scarpello JH, Vinik AI, Owyang C. The intestinal phase of pancreatic polypeptide release. Gastroenterology 1982;82:406-12.
99. Johansson C, Kollberg B, Efendic S, Uvnàs-Wallensten K. Effects of graded doses of somatostatin on gallbladder emptying and pancreatic output after oral glucose in man. Digestion 1981;22:24-31.
100. Vagne M, Grossman MI. Cholecystokinetic potency of gastrointestinal hormones and related peptides. Am J Physiol 1968;215:881-4.
101. Amer MS. Studies with cholecystokinin. II. Cholecystokinetic potency of porcine gastrin I and II and related peptides in three systems. Endocrinology 1969;84:1277-81.
102. Yau WM, Makhlouf GM, Edwards LE. Mode of action of cholecystokinin and related peptides on gallbladder muscle. Gastroenterology 1973;65:451-6.
103. Valenzuela JE, Walsh JH, Isenberg JI. Effect of gastrin on pancreatic enzyme secretion and gallbladder emptying in man. Gastroenterology 1976;71:409-11.
104. Ryan J, Cohen S. Pressure-volume response to gastrointestinal hormones. Am J Physiol 1976;230:1461-5.
105. Cameron AJ, Phillips SF, Summerskill WH. Effect of cholecystokinin, gastrin, secretin, and glucagon on human gallbladder in vitro. Proc Soc Exp Biol Med 1969;131:149-53.
106. Ryan J, Cohen S. Interaction of gastrin I, secretin, and cholecystokinin on gallbladder smooth muscle. Am J Physiol 1976;230:553-6.
107. Schusdziarra V, Harris V, Conlon JM, Arimura A, Unger R. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest 1978;62:509-18.
108. Schwartz TW, Grotzinger U, Schoon I-M, Olbe L. Vago-vagal stimulation of pancreatic polypeptide secretion by graded distension of the gastric fundus and antrum in man. Digestion 1979;19:307-14.
109. Sarson DL, Christofides ND, Albuquerque RH, Adrian TE, Ghatei MA, Modlin IM, et al. Release of gastrointestinal hormones after an oral water load and atropine in man. Gut 1978;19:A436.
110. Hallenbeck GA. Biliary and pancreatic intraductal pressures. In: Code CF, editor. Alimentary canal. Section 6, Vol II of Visscher MB, Hastings AB, Pappenheim JR, Rahn H, editors. Handbook of physiology. Baltimore: Waverly Press; 1967. p. 1007-25.
111. Hong SS, Magee DF, Crewdson F. The physiologic regulation of gallbladder evacuation. Gastroenterology 1956;30: 625-30.
112. Jazrawi RP, Pazzi P, Petroni ML, Prandini N, Paul C, Adam JA, et al. Postprandial gallbladder motor function: refilling and turnover of bile in health and cholelithiasis. Gastroenterology 1995;109:582-91.
113. Bühner S, Teyssen S, Kern I, Wienbeck J, Niebergall-Roth E, et al. Gallbladder motility following hormonal and enteral stimuli in dogs. Gastroenterology 1997 (Abstract Digestive Disease Week, Washington D.C.).
114. Sturdevant R, Stern D, Resin H. Effect of graded doses of octapeptide of cholecystokinin on gallbladder in man. Gastroenterology 1973;64:452-6.
115. McGregor IL, Knell JR, Meyer JH. Similar sensitivities of pancreatic and biliary secretion to cholecystokinin plus secretin infusion. Am J Dig Dis 1976;21:641-4.
116. Spellman SJ, Shaffer EA, Rosenthall L. Galbladder emptying in response to cholecystokinin. A cholescintigraphic study. Gastroenterology 1979;77:115-20.
117. Hopman WPM, Kerstens PJSM, Jansen JBMJ, Rosenbusch G, Lamers CBHW. Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output. Gastroenterology 1985;89:1242-7.
118. Amberg J. Canine cholecystokinesis: effect of octapeptide of cholecystokinin. Radiology 1974;100:223-4.
119. Jansson R, Svanvik J. Effects of intravenous secretin and cholecystokinin on gallbladder net water absorption and motility in the cat. Gastroenterology 1977;72:639-43.
120. Chowdhury JR, Berkowitz JM, Praissiman M, Fora JW. Interaction between octapeptide-cholecystokinin, gastrin, and secretin on cat gallbladder in vitro. Am J Physiol 1975; 229:1311-5.
121. Amer MS. Studies with cholecystokinin in vitro. III. Mechanism of the effect on the isolated gallbladder strip. J Pharmacol Exp Ther 1972;183:527-34.
122. Hedner P. Effect of the C-terminal octapeptide of cholecystokinin on guinea pig ileum and gallbaldder in vitro. Acta Physiol Scand 1970;78:232-5.
123. Lamers CBHW, Poitras WP, Jansen JBMJ, Walsh JH. Relative potencies of cholecystokinin-33 and cholecystokinin-8 measured by radioimmunoassay and bioassay. Scand J Gastroenterol 1983;18 Suppl 83:191-2.
124. Solomon TE, Yamada T, Elashoff J, Wood J, Beglinger C. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33. Am J Physiol 1984;247:G105-11.
125. Rehfeld JF. How to measure cholecystokinin in plasma? Gastroenterology 1984;87:434-8.
126. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA. Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985;75:1144-52.
127. Rehfeld JF. The molecular nature of cholecystokinin in plasma. An in vivo immunosorption study in rabbits. Scand J Gastroenterol 1994;29:110-21.
128. Wiener I, Inoue K, Fagan CJ, Lilja P, Watson LC, Thompson JC. Release of cholecystokinin in man. Correlation of blood levels with gallbladder contraction. Ann Surg 1981; 194:321-7.
129. Lin T-M. Actions of gastointestinal hormones and related peptides on the motor function of the biliary tract. Gastroenterology 1975;69:1006-22.
130. Thompson JC, Fried GM, Ogden WD, Fagan CJ, Inoue K, Wiener I, et al. Correlation between release of cholecystokinin and contraction of the gallbladder in patients with gallstones. Ann Surg 1982;195:670-6.
131. Hopman WPM, Jansen JBMJ, Lamers CBHW. Effect of equimolar amounts of long chain triglycerides and medium chain triglycerides on plasma cholecystokinin and gallbladder contraction. Am J Nutr 1984;39:356-9.
132. Hopman WPM, Jansen JBMJ, Lamers CBHW. Effect of atropine on plasma cholecystokinin response to intraduodenal fat in man. Digestion 1984;29:19-25.
133. Hopman WPM, Jansen JBMJ, Rosenbusch G, Lamers CBHW. Role of cholecystokinin and the cholinergic system in intestinal stimulation of gallbladder contraction in man. Hepatology 1990;11:261-5.
134. Fried GM, Ogden WD, Greeley GH Jr, Thompson JC. Correlation of release and actions of cholecystokinin in dogs before and after vagotomy. Surgery 1983;93:786-91.
135. Fried GM, Ogden WD, Swierczek J, Greeley GH Jr, Rayford PL, Thompson JC. Release of cholecystokinin in conscious dogs: correlation with simultaneous measurements of gallbladder pressure and pancreatic protein secretion. Gastroenterology 1983;85:1113-9.
136. Shiratori K, Watanabe S, Chey WY, Lee KY, Chang T-M. Endogenous cholecystokinin drives gallbladder emptying in dogs. Am J Physiol 1986;251:G553-8.
137. Lilja P, Fagan CJ, Wiener I, Inoue K, Watson LC, Rayford PL, et al. Infusion of pure cholecystokinin in humans. Correlation between plasma concentrations of cholecystokinin and gallbladder size. Gastroenterology 1982;83:256-61.
138. Kerstens PJSM, Lamers CBHW, Jansen JBMJ, DeJong AJL, Hessels M, Hafkenscheid JCM. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. Life Sci 1985; 36:565-9.
139. Beglinger C, Hildebrand P, Adler G, Werth B, Luo H, Delco F, Gyr K. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man. Eur J Clin Invest 1992; 22:827-34.
140. Pendleton RG, Bendesky RJ, Schaffer L, Nolan TE, Gould RJ, Clineschmidt BV. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist. J Pharmacol Exp Ther 1987;241:110-6.
141. Setnikar I, Bani M, Cereda R, Chisté E, Makovec F, Pacini MA, et al. Anticholecystokinin activities of loxiglumide. Drug Res 1987;37:1168-71.
142. Behar J, Biancani P. Pharmacologic characterization of excitatory and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of Oddi. Gastroenterology 1987;92: 764-70.
143. Takahashi T, Yamamura T, Kusunoki M, Kantoh M, Ishikawa Y, Utsunomiya J. Differences between muscular receptors and neuronal receptors for cholecystokinin-octapeptide in the guinea-pig gallbladder. Eur J Pharmacol 1987;136:255-8.
144. Hanyu N, Dodds WJ, Layman RD, Hogan WJ, Chey WY, Takhashi I. Mechanism of cholecystokinin-induced contraction of the opposum gallbladder. Gastroenterology 1990;98:1299-306.
145. Persson CGA, Ekman M. Effect of morphine, CCK, and sympathomimetics on the sphincter of Oddi and intestinal pressure in the cat duodenum. Scand J Gastroenterol 1972; 7:345-51.
146. Ondetti MA, Rubin B, Engel SL. Cholecystokinin-pancreozymin: recent developments. Am J Dig Dis 1970;15: 149-56.
147. Grossman MI, Konturek SJ. Gastric acid does drive pancreatic bicarbonate secretion. Scand J Gastroenterol 1974;9:299-302.
148. Stening GF, Grossman MI. Potentiation of the action of cholecystokinin by secretin. Clin Res 1969;17:528A.
149. Lin T-M, Spray GF. Effect of pentagastrin, cholecystokinin, caerulein and glucagon on the choledochal resistance of bile flow of dogs. Gastroenterology 1969;56:1178.
150. Taylor IL, Kauffman GL Jr, Walsh JH, Trout H, Chew P, Harmon JW. Role of the small intestine and gastric antrum in pancreatic polypeptide release. Am J Physiol 1981;240:G387-91.
151. Greenberg GR, McCloy RF, Adrian TE, Chadwick VS, Baron JH, Bloom SR. Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet 1978;1978:1280-2.
152. Conter RL, Roslyn JJ, DenBesten L, Taylor IL. Pancreatic polypeptide enhances postcontractile gallbladder filling in the prairie dogs. Gastroenterology 1987;92:771-6.
153. Mitznegg P, Bloom SR, Christofides N, Bestermann H, Domschke W, Domsche S, et al. Release of motilin in man. Scand J Gastroenterol 1976;11 Suppl 39:53-6.
154. Fisher RS, Rock E, Malmud LS. Cholinergic effects on gallbladder emptying in humans. Gastroenterology 1985;89: 716-22.
155. Gullo L, Bolondi L, Priori P, Casanova P, Labò G. Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man. Digestion 1984;29:209-13.
156. Marzio L, DiGiammarco AM, Neri M, Cuccurullo F, Malfertheiner P. Atropine antagonizes cholecystokinin and cerulein-induced gallbladder evacuation in man: a real-time ultrasonographic study. Am J Gastroenterol 1985;80:1-4.
157. Niebergall-Roth E, Teyssen S, Rippel K, Korn A, Singer MV. Latency of intraluminal gallbladder pressure in response to intraduoenal stimulants in dogs - first results. Digestion 1997 (Abstract European Pancreatic Club, London, U.K.).
158. Takahashi I, Dodds WJ, Hogan WJ, Baker K, Itoh Z. Effect of vagotomy on changes in gallbladder volume during fasting and after feeding on the conscious opossum. Gastroenterology 1984;86:1273.
159. Fletcher DM, Clark DG. Changes in canine bile-flow and composition after vagotomy. Br J Surg 1969;56:103-6.
160. Amdrup BM, Griffith CA. The effect of vagotomy upon biliary function in dogs. J Surg Res 1970;10:209-12.
161. Pallin B, Skoglund S. Neural and humoral control of the gallbladder emptying mechanism in the cat. Acta Physiol Scand 1964;60:358-62.
162. Bertaccini G, DeCaro G, Endean R, Erspamer V, Impicciatore M. The action of caerulein on the smooth muscle of the gastrointestinal tract and the gallbladder. Br J Pharmacol 1986; 34:291-310.
163. Andersson KE, Andersson R, Hedner P. Cholecystokinetic effect and concentration of cyclic AMP in gallbladder muscle in vitro. Acta Physiol Scand 1972;85:511-6.
164. Persson CGA. Adrenergic, cholecystokinetic and morphine induced effects on extra-hepatic biliary motility. Acta Physiol Scand 1972;87 Suppl: 1-32.
165. Davison JS, Al-Hassani M. The role of non-cholinergic non-adrenergic nerves in regulating the distensibility of the guinea pig gallbladder. In: Christensen J, editor. Gastrointestinal motility. New York: Raven Press; 1980. p. 89-95.
166. Takahashi T, Yamamura Y, Ishikawa M, Kantoh M, Utsonomiya J. Effects of cholecystokinin-octapeptide on the human gallbladder both in vivo and in vitro. Gastroenterol Jpn 1986;21:49-54.
167. Zabrin MA, Wamsley JK, Innis RB, Kuhar MJ. Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. Life Sci 1981;29:697-705.
168. Dockray GJ. Vagally mediated actions of CCK. In: Adler G, Beglinger C, editors. Cholecystokinin antagonists in gastroenterology. Heidelberg: Springer; 1991. p. 56-62.
169. Yegen BC, Tankhurt E, Gurmen N, Bayram M, Oktay S, Ulusoy NB. Inhibition of cholecystokinin-induced gallbladder contraction by atropine and pirenzepine in man. Digestion 1990;45:176-80.
170. Fosel S, Sewing DF. Enhancement of electrically stimulated guinea pig gallbladder contraction by subtreshold concentration of gastrointestinal hormones in vitro. Experientia 1978; 34:205-6.
171. Layer P, Gröger G. Regulation gastrointestinaler Funktionen durch die Ileozökalregion. Z Gastroenterol 1992;30:873-7.
172. Bond JH Jr, Levitt D. Fate of soluble carbohydrate in the colon of rats and man. J Clin Invest 1976;57:1158-64.
173. Stephen AM, Haddad AC, Phillips SF. Passage of carbohydrate into the colon. Direct measurements in humans. Gastroenterology 1983;92:383-9.
174. Mühlum A, Junker S, Meyer H. Precaecal and postileal digestibility of various fats. In: Meyer H, editor. Contributions of digestive physiology of dogs. Hamburg: Parey; 1989. p. 24-30.
175. Jain NK, Boivin M, Zinsmeister AR, DiMagno EP. The ileum and carbohydrate-mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans. Pancreas 1991; 6:495-505.
176. Birch CL, Boyden EA. Reaction of gallbladder to stimulation of gastrointestinal tract. II. Response to faradic excitation of stomach, small intestine and caecum. Am J Physiol 1930; 92:301.
177. Owyang C, Green L, Rader D. Colonic inhibition of pancreatic and biliary secretion. Gastroenterology 1983;84:470-5.
178. Sarles H, Dahl C, Badetti J. Etude de l'action des corps gras sur la contraction vésiculaire - Mise en évidence d'un phénomène hormonal inhibant contraction vésiculaire. Nutr Diet 1960;2: 223-9.
179. Harper AA, Hood AJC, Mushens J, Smy R. Pancreotone, an inhibitor of pancreatic secretion in extracts of ileal and colonic mucosa. J Physiol 1979;292:455-67.
180. Feurle GE, Büchler M, Helmstadter V. Gastric and enteral pancreatic polypeptide (PP) immunoreactivity in the dog. Acta Histochem 1985;77:151-8.
181. Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz P, Barnes AJ. Distribution and release of human pancreatic polypeptide. Gut 1976;17:940-4.
182. Rouller D, Schusdziarra V, Conlon JM, Harris V, Unger RH. Release of somatostatin-like immunoreactivity from the lower gut. Gastroenterology 1979;77:700-3.
183. Tatemoto K. Isolation and characterization of peptide YY (PYY). a candidate gut hormone that inhibits pancreatic excrine secretion. Proc Natl Acad Sci USA 1982;79:2514-8.
184. Niebergall-Roth E, Teyssen S, Singer MV. Effects of peptide YY on gastrointestinal functions. Dtsch Tieraerztl Wochenschr 1997;104:108-13.
185. Niebergall-Roth E, Teyssen S, Singer MV. Neurohormonal control of pancreatic exocrine secretion by intraileal and intracolonic nutrients. Dtsch Tieraerztl Wochenschr 1995; 102:385-91.
186. Conter RL, Roslyn JJ, Taylor IL. Effects of peptide YY on gallbladder motility. Am J Physiol 1987;252:G736-41.
187. Grace PA, Couse NF, Taylor IL, Pitt AH. Peptide YY inhibits cholecystokinin-stimulated sphincter of oddi in the prairie dog. Surgery 1988;104:546-52.
188. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, et al. Effect of peptide YY on gastric, pancreatic and biliary function in humans. Gastroenterology 1985;89: 494-9.
189. Lluis F, Fujimura M, Lonovics J, Guo Y-S, Gomez G, Greeley GH Jr, et al. Peptide YY and galbladder contraction. Gastroenterology 1988;94:1441-6.
190. Baba H, Fujimura M, Toda N. Mechanism of inhibitory action of peptide YY
191. Niebergall-Roth E, Teyssen S, Wetzel D, Hartel M, Beglinger C, Riepl RL, et al. Effects of telenzepine and L-364,718 on canine pancreatic secretion before and after vagotomy. Am J Physiol 1997. In press.
192. Singer MV, Solomon TE, Wood J, Grossman MI. Latency of pancreatic enzyme response to intraduodenal stimulants. Am J Physiol 1980;238:G23-9.